Abstract
The study was conducted of National Center for Obesity Treatment in Mosul city, from December 2020 to March 2021. The study included (112) woman whose age range between (15-55→) year, (84) of them were obese women and (28) of them were women with normal weight, depending on body mass index BMI value. They were divided into four age groups [(15-25), (25-35), (35-45), (45-55→) year]. All women (not suffering from diabetic mellitus or heart diseases). Blood samples were collected from women whose fasting period of (12-14) hour, serum samples were separated and stored in capped tubes, then we measured the level of Ghrelin hormone, lipid profile [total cholesterol (TC), Triglyceride (TG), High density lipoprotein (HDL), Low density lipoprotein (LDL), Very low-density lipoprotein (VLDL), Atherogenic index (AI)], and measured the level of C-peptide hormone and Glucose (to calculate insulin resistance). The results indicated that the level of ghrelin hormone decreased in obesity (the differences between control and obese groups were significant at P≤0.05) but lipid profile and insulin resistance increased except HDL decrease in obesity (the differences between control and obese groups were significant at P≤0.05). © 2020 NIODC. All rights reserved
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
